A detailed history of Adage Capital Partners Gp, L.L.C. transactions in Surmodics Inc stock. As of the latest transaction made, Adage Capital Partners Gp, L.L.C. holds 91,270 shares of SRDX stock, worth $3.8 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
91,270
Holding current value
$3.8 Million
% of portfolio
0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 14, 2025

BUY
$29.0 - $38.0 $2.65 Million - $3.47 Million
91,270 New
91,270 $2.73 Million
Q4 2021

Feb 14, 2022

SELL
$43.21 - $57.6 $4.32 Million - $5.76 Million
-100,000 Closed
0 $0
Q3 2021

Nov 15, 2021

BUY
$52.8 - $60.32 $5.28 Million - $6.03 Million
100,000 New
100,000 $5.56 Million

Others Institutions Holding SRDX

About SURMODICS INC


  • Ticker SRDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 14,005,000
  • Market Cap $583M
  • Description
  • Surmodics, Inc., together with its subsidiaries, provides surface modification technologies for intravascular medical devices, and chemical components for in vitro diagnostic immunoassay tests and microarrays in the United States and internationally. It operates in two segments, Medical Device and In Vitro Diagnostics (IVD). The Medical Device s...
More about SRDX
Track This Portfolio

Track Adage Capital Partners Gp, L.L.C. Portfolio

Follow Adage Capital Partners Gp, L.L.C. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Adage Capital Partners Gp, L.L.C., based on Form 13F filings with the SEC.

News

Stay updated on Adage Capital Partners Gp, L.L.C. with notifications on news.